Genenta Science
Innovative gene transfer strategies for tumour treatment
Genenta Science has raised €9.3M across 2 funding rounds, most recently a Series A round in Mar 2015. Based in Milan, Italy; active in Healthtech. Data as of 28 Oct 2026.
Milan, Italywww.genenta.com ↗
Total raised
€9.3M
€9,311,102
Funding rounds
2
Investors
0
distinct backers
Active since
2015-01
latest 2015-03
Funding by year
EUR raised per yearGenenta Science — funding by year — interactive chart.
Data table
| Genenta Science — funding by year | |
|---|---|
| 2014 | €5.9M |
| 2015 | €3.4M |
Signals
Medium confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-03-01 | Series A | €3.4M | — | View deal → |
| 2015-01-01 | Series A | €5.9M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData